Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Technology Cancer Hospital (TCH) is a specialized biotechnology company and clinical institution focused on the development and application of advanced cancer immunotherapies. The company integrates clinical research with therapeutic development, particularly in the fields of CAR-T and NK cell therapies for both hematological malignancies and solid tumors. TCH operates specialized facilities that allow for rapid translation of laboratory discoveries into clinical trials, maintaining a robust pipeline of next-generation immune cell products. Their business model combines high-end oncology services with proprietary drug development, positioning them as a vertically integrated player in the precision medicine space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technology Cancer Hospital.